Eevia announce that the rights issue was fully subscribed
THIS PRESS RELEASE MAY NOT BE MADE PUBLIC, PUBLISHED, OR DISTRIBUTED, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, HONG KONG, JAPAN, CANADA, NEW ZEALAND, SINGAPORE, SOUTH AFRICA, SOUTH KOREA, OR ANY OTHER JURISDICTION IN WHICH SUCH ACTIONS, WHOLLY OR IN PART, WOULD BE UNLAWFUL OR DEMAND ADDITIONAL REGISTRATION OR OTHER MEASURES. PLEASE REFER TO “IMPORTANT INFORMATION” AT THE END OF THIS PRESS RELEASE. Eevia Health Plc (“Eevia” och “the Company") announces today the outcome of the Rights Issue, whose subscription period ended on November 15, 2022, where a